These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10197254)

  • 1. Vaccines against bovine babesiosis--longest field trial?
    Angus BM
    Aust Vet J; 1999 Mar; 77(3):193. PubMed ID: 10197254
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
    Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
    Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
    Lawrence JA; Malika J; Whiteland AP; Kafuwa P
    Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations of breakdowns in protection provided by living Babesia bovis vaccine.
    Bock RE; de Vos AJ; Kingston TG; Shiels IA; Dalgliesh RJ
    Vet Parasitol; 1992 Jun; 43(1-2):45-56. PubMed ID: 1496802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for recombinant vaccines against Babesia bovis and related parasites.
    Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
    Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cattle responses to mono-specific or combined inoculations with Babesia bigemina and Babesia bovis vaccine strains.
    Viseras J; Lugaresi CI; Volpogni MM; Guglielmone AA
    Parasite; 1999 Mar; 6(1):67-9. PubMed ID: 10229940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
    Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
    Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live vaccines against bovine babesiosis.
    de Waal DT; Combrink MP
    Vet Parasitol; 2006 May; 138(1-2):88-96. PubMed ID: 16504404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
    Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
    Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of Babesia bovis 6cys A and 6cys B as components of transmission blocking vaccines for babesiosis.
    Alzan HF; Bastos RG; Ueti MW; Laughery JM; Rathinasamy VA; Cooke BM; Suarez CE
    Parasit Vectors; 2021 Apr; 14(1):210. PubMed ID: 33879245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated trivalent vaccine against babesiosis and anaplasmosis in Colombia.
    Benavides E; Vizcaino O; Britto CM; Romero A; Rubio A
    Ann N Y Acad Sci; 2000; 916():613-6. PubMed ID: 11193685
    [No Abstract]   [Full Text] [Related]  

  • 12. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
    Montenegro-James S; Toro M; Leon E; Guillen AT
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Babesia bovis: analysis of and preliminary vaccination studies with a defined infected erythrocyte membrane binding antigen.
    Goodger BV; Waltisbuhl DJ; Wright IG; White M
    Int J Parasitol; 1992 Jul; 22(4):533-5. PubMed ID: 1644530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking Babesia bovis vaccine reactions of dairy cattle in milk.
    Combrink MP; Carr G; Mans BJ; Marais F
    Onderstepoort J Vet Res; 2012 Dec; 79(1):E1-4. PubMed ID: 23327323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological responses to Babesia bovis vaccination in cattle previously infected with Babesia bigemina.
    Combrink MP; Troskie PC; Du Plessis F; Latif AA
    Vet Parasitol; 2010 May; 170(1-2):30-6. PubMed ID: 20207488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Babesia bovis live attenuated vaccine.
    Alonso M; Blandino T; Mendoza E; Savon L; Camacho M
    Arch Med Res; 1994; 25(2):273-7. PubMed ID: 7919825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of effective living vaccines against bovine babesiosis--the longest field trial?
    Callow LL; Dalgliesh RJ; de Vos AJ
    Int J Parasitol; 1997 Jul; 27(7):747-67. PubMed ID: 9279577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of South African Babesia bovis vaccine against field isolates.
    Troskie PC; Latif AA; Mans BJ; Combrink MP
    Ticks Tick Borne Dis; 2017 Jun; 8(4):671-674. PubMed ID: 28499721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico.
    Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA
    Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between vaccine and virulent strains of Babesia bovis during co-infection in calves.
    Jorgensen WK; Jeston PJ; Bowles PM; Croft J; Lew AE; Molloy JB; Dalgliesh RJ
    Aust Vet J; 1998 Jan; 76(1):57-8. PubMed ID: 9578770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.